EUVIMEDEUVIMED entdecken
Crossref

Fragile X syndrome in the largest world clustering. I. Genetic epidemiology and founder effect outline

Julián Ramírez-Cheyne, Diana López, César Payán-Gómez, Mauricio Arcos-Burgos, Wilmar Saldarriaga

American Journal of Medical Genetics Part A · 2024

DOI: 10.1002/ajmg.a.63523 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Julián Ramírez-Cheyne und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario del Valle, Universidad del Valle, Cali, Colombia. Hauptthemen laut MEDLINE: Fragile X Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The FMR1 5′ regulation gene region harbors a CGG trinucleotide repeat expansion (CGG‐TRE) that causes Fragile X syndrome (FXS) when it expands to more than 200 repetitions. Ricaurte is a small village in southwestern Colombia, with an FXS prevalence of 1 in 38 men and 1 in 100 women (~100 times higher than the worldwide reported prevalence), defining Ricaurte as the largest FXS cluster in the world. In the present study, using next‐generation sequencing of whole exome capture, we genotype 55 individuals from Ricaurte (49 with either full mutation or with premutation), four individuals from neighboring villages (with either the full mutation or with the premutation), and one unaffected woman, native of Ricaurte, who did not belong to any of the affected families. With advanced clustering and haplotype reconstruction, we modeled a common haplotype of 33 SNPs spanning 83,567,899 bp and harboring the FMR1 gene. This reconstructed haplotype was found in all the men from Ricaurte who carried the expansion, demonstrating that the genetic conglomerate of FXS in this population is due to a founder effect. The definition of this founder effect and its population outlining will allow a better prediction, follow‐up, precise and personalized characterization of epidemiological parameters, better knowledge of the disease's natural history, and confident improvement of the clinical attention, life quality, and health interventions for this community.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fragile X SyndromeMaleHumansFemaleFounder EffectMolecular EpidemiologyFragile X Messenger Ribonucleoprotein 1Trinucleotide Repeat ExpansionMutation

Stichwörter der Autor:innen

ColombiaFMR1Fragile X syndromeexomic sequencingfounder effectpopulation isolates

Substanzen

Fragile X Messenger Ribonucleoprotein 1FMR1 protein, human

Autor:innen und Institutionen

  • Hospital Universitario del Valle, Universidad del Valle, Cali, Colombia.
  • Department of Biological Science, Faculty of Agricultural Sciences, Universidad Nacional de Colombia, Palmira, Colombia.
  • Dirección Académica, Universidad Nacional de Colombia. Sede de La Paz. Cesar, Colombia.
  • Instituto de Investigaciones Médicas, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.

Zitieren

APA

Ramírez-Cheyne, J., López, D., Payán-Gómez, C., Arcos-Burgos, M., & Saldarriaga, W. (2024). Fragile X syndrome in the largest world clustering. I. Genetic epidemiology and founder effect outline. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63523

Vancouver

Ramírez-Cheyne J, López D, Payán-Gómez C, Arcos-Burgos M, Saldarriaga W. Fragile X syndrome in the largest world clustering. I. Genetic epidemiology and founder effect outline. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63523

BibTeX
@article{RamrezCheyne2024,
  author = {Ramírez-Cheyne, Julián and López, Diana and Payán-Gómez, César and Arcos-Burgos, Mauricio and Saldarriaga, Wilmar},
  title = {Fragile X syndrome in the largest world clustering. I. Genetic epidemiology and founder effect outline},
  journal = {American Journal of Medical Genetics Part A},
  year = {2024},
  doi = {10.1002/ajmg.a.63523}
}
Kostenlos starten →